First Time Loading...

ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 1.08 USD -6.09% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

ABVC Price Targets Summary
ABVC Biopharma Inc

Wall Street analysts forecast ABVC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABVC is 2.02 USD .

Lowest
Price Target
Not Available
Average
Price Target
2.02 USD
87% Upside
Highest
Price Target
Not Available
ABVC Biopharma Inc Competitors:
Price Targets
VIMTALABS
Vimta Labs Ltd
42% Upside
CRBU
Caribou Biosciences Inc
441% Upside
CLSD
Clearside Biomedical Inc
328% Upside
IVA
Inventiva SA
293% Upside
LQDA
Liquidia Corp
101% Upside
SRZN
Surrozen Inc
237% Upside
ITCI
Intra-Cellular Therapies Inc
36% Upside
NTLA
Intellia Therapeutics Inc
207% Upside

Revenue
Forecast

Revenue Estimate
ABVC Biopharma Inc

The compound annual growth rate of ABVC Biopharma Inc's revenue for the next 2 years is 428%.

N/A
Past Growth
428%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ABVC Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

Net Income
Forecast

Net Income Estimate
ABVC Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABVC's stock price target?
Price Target
2.02 USD

According to Wall Street analysts, the average 1-year price target for ABVC is 2.02 USD .

What is ABVC Biopharma Inc's Revenue forecast?
Projected CAGR
428%

The compound annual growth rate of ABVC Biopharma Inc's revenue for the next 2 years is 428%.